Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 109

1.

Terminal elimination plasma half-life of delta 1-tetrahydrocannabinol (delta 1-THC) in heavy users of marijuana.

Johansson E, Halldin MM, Agurell S, Hollister LE, Gillespie HK.

Eur J Clin Pharmacol. 1989;37(3):273-7.

PMID:
2558889
2.

Prolonged apparent half-life of delta 1-tetrahydrocannabinol in plasma of chronic marijuana users.

Johansson E, Agurell S, Hollister LE, Halldin MM.

J Pharm Pharmacol. 1988 May;40(5):374-5.

PMID:
2899638
3.

Single-dose kinetics of deuterium-labelled cannabinol in man after intravenous administration and smoking.

Johansson E, Ohlsson A, Lindgren JE, Agurell S, Gillespie H, Hollister LE.

Biomed Environ Mass Spectrom. 1987 Sep;14(9):495-9.

PMID:
2960395
4.

Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man.

Agurell S, Halldin M, Lindgren JE, Ohlsson A, Widman M, Gillespie H, Hollister L.

Pharmacol Rev. 1986 Mar;38(1):21-43. Review. No abstract available.

PMID:
3012605
5.

Single-dose kinetics of deuterium-labelled cannabidiol in man after smoking and intravenous administration.

Ohlsson A, Lindgren JE, Andersson S, Agurell S, Gillespie H, Hollister LE.

Biomed Environ Mass Spectrom. 1986 Feb;13(2):77-83.

PMID:
2937482
6.
7.
8.

Urinary metabolites of delta 1-tetrahydrocannabinol in man.

Halldin MM, Carlsson S, Kanter SL, Widman M, Agurell S.

Arzneimittelforschung. 1982;32(7):764-8.

PMID:
6289845
9.

Single dose kinetics of deuterium labelled delta 1-tetrahydrocannabinol in heavy and light cannabis users.

Ohlsson A, Lindgren JE, Wahlén A, Agurell S, Hollister LE, Gillespie HK.

Biomed Mass Spectrom. 1982 Jan;9(1):6-10.

PMID:
6277407
10.

Interactions of delta 1-tetrahydrocannabinol with cannabinol and cannabidiol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentography.

Agurell S, Carlsson S, Lindgren JE, Ohlsson A, Gillespie H, Hollister L.

Experientia. 1981 Oct 15;37(10):1090-2. No abstract available.

PMID:
6273208
11.

Do plasma concentrations of delta 9-tetrahydrocannabinol reflect the degree of intoxication?

Hollister LE, Gillespie HK, Ohlsson A, Lindgren JE, Wahlen A, Agurell S.

J Clin Pharmacol. 1981 Aug-Sep;21(8-9 Suppl):171S-177S.

PMID:
6271822
12.

Plasma levels of delta 9-tetrahydrocannabinol after intravenous, oral, and smoke administration.

Ohlsson A, Lindgren JE, Wahlen A, Agurell S, Hollister LE, Gillespie HK.

NIDA Res Monogr. 1981 Feb;34:250-6. No abstract available.

PMID:
6261133
13.

Biogenic amines and depression (introduction to symposium).

Agurell S.

Acta Psychiatr Scand Suppl. 1981;290:17-9.

PMID:
6939311
14.

Clinical effects and plasma levels of delta 9-tetrahydrocannabinol (delta 9-THC) in heavy and light users of cannabis.

Lindgren JE, Ohlsson A, Agurell S, Hollister L, Gillespie H.

Psychopharmacology (Berl). 1981;74(3):208-12.

PMID:
6267648
15.

[Recent studies on cannabis or marihuana].

do Valle JR, Agurell S.

Rev Paul Med. 1980 Nov-Dec;96(5-6):81-8. Review. Portuguese. No abstract available.

PMID:
6261320
16.

Plasma delta-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking.

Ohlsson A, Lindgren JE, Wahlen A, Agurell S, Hollister LE, Gillespie HK.

Clin Pharmacol Ther. 1980 Sep;28(3):409-16.

PMID:
6250760
17.

Investigation on the mutagenicity in the Ames test of 1 alpha,2 alpha-epoxyhexahydrocannabinol and its conversion by deactivating enzymes.

Ohlsson A, Agurell S, Glatt H, Bently P, Oesch F.

Acta Pharm Suec. 1980;17(4):189-98. No abstract available.

PMID:
6258386
18.

Chemical synthesis and biological occurrence of carboxylic acid metabolites of delta1(6)-tetrahydrocannabinol.

Agurell S, Edward C, Halldin M, Leander K, Levy S, Lindgren JE, Mechoulam R, Noreqvist M, Ohlsson A.

Drug Metab Dispos. 1979 May-Jun;7(3):155-61.

PMID:
38086
19.
20.

More acidic metabolites of delta1-tetrahydrocannabinol isolated from rabbit urine.

Nordqvist M, Agurell S, Rydberg M, Falk L, Ryman T.

J Pharm Pharmacol. 1979 Apr;31(4):238-43.

PMID:
36463
21.

Acidic metabolites of delta1-tetrahydrocannabinol isolated from rabbit urine.

Nordqvist M, Lindgren JE, Agurell S.

J Pharm Pharmacol. 1979 Apr;31(4):231-7.

PMID:
36462
22.

Synthesis and psychotropic activity of side-chain hydroxylated delta6-tetrahydrocannabinol metabolites.

Ohlsson A, Agurell S, Leander K, Dahmén J, Edery H, Porath G, Levy S, Mechoulam R.

Acta Pharm Suec. 1979;16(1):21-33. No abstract available.

PMID:
110030
23.

Pharmacokinetics of clomethiazole in healthy adults.

Jostell KG, Agurell S, Allgén LG, Kuylenstierna B, Lindgren JE, Aberg G, Osterlöf G.

Acta Pharmacol Toxicol (Copenh). 1978 Sep;43(3):180-9.

PMID:
707131
24.

Acidic in vivo metabolites of cannabinol isolated from rat faeces.

Yisak AW, Widman M, Agurell S.

J Pharm Pharmacol. 1978 Sep;30(9):554-7.

PMID:
29093
25.

Relation between effects of cannabinoid derivatives on the twitch response of the isolated guinea-pig ileum and their psychotropic properties.

Rosell S, Björkroth U, Agurell S, Leander K, Ohlsson A, Martin B, Mechoulam R.

Adv Biosci. 1978 Jul 22-23;22-23:63-70. No abstract available.

PMID:
756848
26.

Introduction to quantification of cannabinoids and their metabolites in biological fluids.

Agurell S, Lindgren JE, Ohlsson A.

Adv Biosci. 1978 Jul 22-23;22-23:3-13. No abstract available.

PMID:
756831
27.

In vivo metabolites of cannabinol identified as fatty acid conjugates.

Yisak W, Agurell S, Lindgren JE, Widman M.

J Pharm Pharmacol. 1978 Jul;30(7):462-3. No abstract available.

PMID:
27621
28.

Kinetics of chlormethiazole in patients with alcohol withdrawal manifestations.

Jostell KG, Agurell S, Hollister LE, Wermuth B.

Clin Pharmacol Ther. 1978 Feb;23(2):181-7.

PMID:
620478
29.

Perfusion of the isolated rat brain with [14C]-delta1-tetrahydrocannabinol.

Martin B, Agurell S, Krieglstein J, Rieger H.

Biochem Pharmacol. 1977 Dec 1;26(23):2307-9. No abstract available.

PMID:
588312
30.

Neutral in vivo metabolites of cannabinol isolated from rat faeces.

Yisak WA, Widman M, Lindgren JE, Agurell S.

J Pharm Pharmacol. 1977 Aug;29(8):487-90.

PMID:
19598
31.

In vivo neutral metabolites of cannabinol from rat faeces [proceedings].

Yisak WA, Widman M, Agurell S, Lindren JE.

West Afr J Pharmacol Drug Res. 1977 Jun;4(1):83P-84P. No abstract available.

PMID:
602206
32.

In vivo neutral metabolites of cannabinol from rat faeces [proceedings].

Yisak WA, Widman M, Agurell S, Lindgren JE.

West Afr J Pharmacol Drug Res. 1977 Jun;4(1):61P. No abstract available.

PMID:
602189
33.

[Detection of cannabis use and relation of its pharmacokinetics to its effects in man].

Agurell S.

Lakartidningen. 1976 Nov 3;73(45):3860-3. Swedish. No abstract available.

PMID:
979451
34.

Dioxygenated metabolites of cannabidiol formed by rat liver.

Martin B, Agurell S, Nordqvist M, Lindgren JE.

J Pharm Pharmacol. 1976 Aug;28(8):603-8.

PMID:
11306
35.

A method for the identification of acid metabolites of tetrahydrocannabinol (THC) by mass fragmentography.

Nordqvist M, Lindgren JE, Agurell S.

NIDA Res Monogr. 1976 May;(7):64-9. No abstract available.

PMID:
967241
36.

Detection and quantification of tetrahydrocannabinol in blood plasma.

Ohlsson A, Lindgren JE, Leander K, Agurell S.

NIDA Res Monogr. 1976 May;(7):48-63. No abstract available.

PMID:
967240
37.

Identification of monohydroxylated metabolites of cannabidiol formed by rat liver.

Martin B, Nordqvist M, Agurell S, Lindgren JE, Leander K, Binder M.

J Pharm Pharmacol. 1976 Apr;28(4):275-9.

PMID:
6714
38.

Total synthesis of cannabidiol and delta1-tetrahydrocannabinol metabolites.

Lander N, Ben-Zvi Z, Mechoulam R, Martin B, Nordqvist M, Agurell S.

J Chem Soc Perkin 1. 1976;(1):8-16. No abstract available.

PMID:
942726
39.

Quantitation of phenobarbital and its main metabolites in human urine.

Kallberg N, Agurell S, Ericsson O, Bucht E, Jalling B, Boréus LO.

Eur J Clin Pharmacol. 1975 Dec 19;9(2-3):161-8.

PMID:
1233264
40.

Proceedings: Pharmacokinetics in relation to physiological and psychological effects of delta-8-THC.

Levander S, Binder M, Agurell S, Bader-Bartfai A, Gustafsson K, Lindgren J, Leander K, Olsson A, Tobisson B.

Acta Pharm Suec. 1974 Dec;11(6):662-3. No abstract available.

PMID:
1094806
41.

Plasma levels of diazepam after parenteral and rectal administration in children.

Agurell S, Berlin A, Ferngren H, Hellström B.

Epilepsia. 1975 Jun;16(2):277-83.

PMID:
1149714
42.

Effects of 7-hydroxy-delta-6-tetrahydrocannabinol and some related cannabinoids on the guinea pig isolated ileum.

Rosell S, Agurell S.

Acta Physiol Scand. 1975 May;94(1):142-4. No abstract available.

PMID:
1155164
43.

Cactaceae alkaloids. XXI. Phenethylamine alkaloids of Coryphantha species.

Bruhn JG, Agurell S.

Acta Pharm Suec. 1975;12(2):199-204. No abstract available.

PMID:
1163237
44.

Binding of (+)- and (minus)-delta-1-tetrahydrocannabinols and (minus)-7-hydroxy-delta-1-tetrahydrocannabinol to blood cells and plasma proteins in man.

Widman M, Agurell S, Ehrnebo M, Jones G.

J Pharm Pharmacol. 1974 Nov;26(11):914-6. No abstract available.

PMID:
4156569
45.

Pentazocine binding to blood cells and plasma proteins.

Ehrnebo M, Agurell S, Boréus LO, Gordon E, Lönroth U.

Clin Pharmacol Ther. 1974 Sep;16(3):424-9. No abstract available.

PMID:
4415010
46.

Monohydroxylated metabolites of delta-1-tetrahydrocannabinol in mouse brain. Comparison with in vitro liver metabolites.

Jones G, Widman M, Agurell S, Lindgren JE.

Acta Pharm Suec. 1974 Jun;11(3):283-94. No abstract available.

PMID:
4839738
47.

Structure of an acidic metabolite of delta1-tetrahydrocannabinol isolated from rabbit urine.

Nordqvist M, Agurell S, Binder M, Nilsson IM.

J Pharm Pharmacol. 1974 Jun;26(6):471-3. No abstract available.

PMID:
4154999
48.

Cactaceae alkaloids. 28. Two new alkaloids from Coryphantha calipensis H. Bravo.

Bruhn JG, Agurell S.

J Pharm Sci. 1974 Apr;63(4):574-6. No abstract available.

PMID:
4828707
49.

Biliary excretion of delta1-tetrahydrocannabinol and its metabolites in the rat.

Widman M, Nordqvist M, Agurell S, Lindgren JE, Sandberg F.

Biochem Pharmacol. 1974 Apr 1;23(7):1163-72. No abstract available.

PMID:
4823449
50.

Relative pharmacological potency in mice of optical isomers of delta 1-tetrahydrocannabinol.

Jones G, Pertwee RG, Gill EW, Paton WD, Nilsson IM, Widman M, Agurell S.

Biochem Pharmacol. 1974 Jan 15;23(2):439-46. No abstract available.

PMID:
4813356

Supplemental Content

Loading ...
Support Center